Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Social Media Perceptions Among Young Adults With Cancer - Online Experiment 1 (SIYA MOS1)

4 november 2026 uppdaterad av: UNC Lineberger Comprehensive Cancer Center

Young adults with cancer experience more loneliness than their non-cancer peers or older cancer survivors. Positive psychology interventions may increase social connectedness; however, evidence-based interventions should be tailored to young adults with cancer and designed for social media. This study conducted an online experiment with young adults with cancer (ages 22-39) to optimize intervention messages.

Studieöversikt

Detaljerad beskrivning

To examine how message types and personal stories influence reactions, the study used a mixed between-within online experiment. The researchers hypothesized that four message types (connected peer advocates, lonely peer advocates, cancer peers, and clinicians) would lead to greater perceived message effectiveness in encouraging positive in-person social interactions and stronger intended message reactions compared with control messages (H1). They also hypothesized that including a personal story (cancer-related or general) would improve perceived message effectiveness and intended message reactions (H2). Unintended message reactions were also explored.

Studietyp

Interventionell

Inskrivning (Faktisk)

505

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • North Carolina
      • Chapel Hill, North Carolina, Förenta staterna, 27599
        • University of North Carolina at Chapel Hill

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

22 år till 39 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Participants must be 22-39 years old at the time of the study
  • Participants must have received a cancer diagnosis at any point between ages 15-39
  • Participants must self-report low-to-moderate psychosocial quality of life (QOL), defined as an average rating of 4 or lower on the National Institutes of Health's (NIH's) validated 2-item Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale (two 5-point items)
  • Participants must use social media

Exclusion Criteria:

  • None

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Connected advocate advice

Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who have successfully created social connections and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Experimentell: Lonely advocate advice

Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who are experiencing loneliness but still try to have social connections and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Experimentell: Peer-to-peer sharing

Participants viewed five social media-based messages consisting of peer-to-peer sharing about connecting with others and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions

Experimentell: Clinician advice

Participants viewed five social media-based messages consisting of photographs of clinicians and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Experimentell: Control messages

Participants were randomized to 1 of 5 message conditions.

Participants were randomized to 1 of 5 message conditions.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Perceived Message Effectiveness (Single-Item Self-Report, 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post make you want to connect in person with people you barely know more often?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Positive Affect (Single-Item Self-Report, 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How good does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater positive affect. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Social Presence (Single Item Adapted From Lazard et al., 2020; 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "When viewing this post, how much do you feel as if someone is talking to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived social presence. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Message Relevance (Single Item Adapted From Jensen et al., 2024; 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How relevant is this post to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived relevance. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Attention (Single Item Adapted From Sutfin et al., 2019; 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post grab your attention?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater attention. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Authenticity (Single-Item Self-Report, 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much do you think this post shares a real perspective?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived authenticity. Ratings were compared across experimental conditions and message type.

Baseline, Up to 1 hour

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Negative Affect, Unintended Reaction (Single-Item Self-Report, 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How bad does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater negative affect (a less favorable reaction). Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Reactance, Unintended Reaction (Single Item Adapted From Hall et al., 2017; 5-Point Scale)
Tidsram: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post annoy you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater reactance (a less favorable reaction). Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Allison J Lazard, PhD, UNC Lineberger Comprehensive Cancer Center

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

27 maj 2025

Primärt slutförande (Faktisk)

23 juli 2025

Avslutad studie (Faktisk)

23 juli 2025

Studieregistreringsdatum

Först inskickad

27 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

4 november 2026

Första postat (Faktisk)

10 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

10 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

4 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • SIYA MOS1 Online Experiment 1
  • R01CA276176 (U.S.S. NIH-anslag/kontrakt)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera